Control of hyperactivity of malignant cells by temporary interference in oxidative phosphorylation and a nonspecific immune stimulation as cancer immunotherapy.
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy / Q000378:metabolism / Q000628:therapy*; D003864:Depression, Chemical; D005998:Glycine / Q000494:pharmacology* / Q000627:therapeutic use; D007167:Immunotherapy; D008297:Male; D051379:Mice; D010085:Oxidative Phosphorylation / Q000187:drug effects*
D005998:Glycine